{"issuance_frequency":"","notes_translated":{"fr":"Santé Canada a entamé un projet d'étiquetage par catégorie pour les traitements hormonaux substitutifs (THS), à la lumière des nouvelles données sur l'innocuité provenant de l'essai clinique mené dans le cadre de la Women's Health Initiative et Women's Health Initiative Memory Study. Ce document est destiné pour guider l'industrie pharmaceutique dans la révision du contenu des monographies de produits et du matériel d'étiquetage connexe. ","en":"Health Canada initiated a Hormone Replacement Therapy (HRT) class labelling project in light of new safety information derived from the results of the Women's Health Initiative (WHI) trial and the Women's Health Initiative Memory Study (WHIMS). This document is intended to help the pharmaceutical industry revise the content of the Product Monograph and associated labelling materials. "},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"a48d3c19-ab7d-4112-86ff-106aaeb63a6f","metadata_created":"2021-07-07T16:42:00.657118","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-07T16:42:00.657124","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-07","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Lignes directrices pour l'industrie","monographies de produits","œstrogènes non contraceptifs","produits contenant un progestatif","hormonothérapie substitutive","informations sur l'innocuité","essai de l'initiative pour la santé des femmes","étude de mémoire de l'initiative pour la santé des femmes"],"en":["Guidance for industry","product monographs","non-contraceptive estrogen","progestin-containing products","hormone replacement therapy","safety information","women's health initiative trial","women's health initiative memory study"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Monographies des produits non contraceptifs contenant des oestrogènes et des progestatifs","en":"Guidance for Industry - Product Monographs of Non-Contraceptive Estrogen/Progestin-Containing Products"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"a48d3c19-ab7d-4112-86ff-106aaeb63a6f","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"08b6b361-5813-4a89-ab38-5523bcd7957b","related_relationship":"","name_translated":{"fr":"Monographies des produits non contraceptifs contenant des oestrogènes et des progestatifs","en":"Guidance for Industry - Product Monographs of Non-Contraceptive Estrogen/Progestin-Containing Products"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for Industry - Product Monographs of Non-Contraceptive Estrogen/Progestin-Containing Products","language":["en"],"created":"2021-07-07T16:42:00.732138","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/hormone-replacement-therapy/industry-product-monographs-non-contraceptive-estrogen-progestin-containing-products.html#a1","last_modified":null,"position":0,"revision_id":"70b3c0a6-601d-444d-8984-778d7e421242","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"a48d3c19-ab7d-4112-86ff-106aaeb63a6f","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e19cc2f5-c4f5-48a3-90a3-d49e62fd7844","related_relationship":"","name_translated":{"fr":"Monographies des produits non contraceptifs contenant des oestrogènes et des progestatifs","en":"Guidance for Industry - Product Monographs of Non-Contraceptive Estrogen/Progestin-Containing Products"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for Industry - Product Monographs of Non-Contraceptive Estrogen/Progestin-Containing Products","language":["fr"],"created":"2021-07-07T16:42:00.732144","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/traitement-hormonal-substitutif/intention-industrie-monographies-produits-non-contraceptifs-contenant-oestrogenes-progestatifs.html#a1","last_modified":null,"position":1,"revision_id":"70b3c0a6-601d-444d-8984-778d7e421242","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2006-04-20 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"a48d3c19-ab7d-4112-86ff-106aaeb63a6f","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Health Canada initiated a Hormone Replacement Therapy (HRT) class labelling project in light of new safety information derived from the results of the Women's Health Initiative (WHI) trial and the Women's Health Initiative Memory Study (WHIMS). This document is intended to help the pharmaceutical industry revise the content of the Product Monograph and associated labelling materials. ","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance for Industry - Product Monographs of Non-Contraceptive Estrogen/Progestin-Containing Products","revision_id":"70b3c0a6-601d-444d-8984-778d7e421242"}